{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:07:40Z","timestamp":1776132460127,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["Public Welfare Project for Rare Disease Service Improvement"],"award-info":[{"award-number":["Public Welfare Project for Rare Disease Service Improvement"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Disorders of sexual development (DSDs) are a group of rare conditions with a discordance of chromosomal, gonadal, or phenotypic features of the internal and\/or external genitalia, which accounts for 0.5% of the population. The precise diagnosis of 46, XY DSDs without uterus is often obscure because of the similar clinical manifestations. Reverse phenotyping based on specific genetic variants helps to identify the cause of these diseases and reduces misdiagnosis caused by limitations in serum tests and imaging.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients with 46, XY DSDs without uterus were enrolled from the Department of Obstetrics and Gynecology, Reproductive Endocrinology and Infertility Center of the Peking Union Medical College Hospital between 2022 and 2023. Comprehensive clinical data, including the social gender, chief complaint, physical examination results and laboratory tests related to sexual development, and surgical information were collected from medical records. Whole exome sequencing (WES) was performed on all patients and the etiological diagnoses were made based on the results. Targeted Sanger sequencing for the candidate gene was performed in the parents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of twenty-one patients with 46, XY DSDs without uterus were included. Twenty-two variants from six genes associated with sex development were identified, including 14 recurrent variants and 8 novel variants. Based on the ACMG guidelines, 17 variants were classified as pathogenic (P) or likely pathogenic (LP), and 5 were defined as variants of uncertain significance (VUS). The genes <jats:italic>LH\/HCG receptor (LHCGR)<\/jats:italic> (2\/22), <jats:italic>CYP17A1<\/jats:italic> (4\/22), <jats:italic>SRD5A2<\/jats:italic> (3\/22), and <jats:italic>AR<\/jats:italic> (10\/22) were involved in steroid hormone synthesis and androgen receptor action, while <jats:italic>NR5A1<\/jats:italic>(2\/22) was associated with gonadal development. Furthermore, a <jats:italic>DHX37<\/jats:italic> variant instead of an <jats:italic>AR<\/jats:italic> variant was identified in a patient clinically diagnosed with complete androgen insensitivity syndrome. Trio-WES revealed three de novo variants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study identified several novel variants broadening the mutation spectrum of 46, XY DSD without uterus. The etiology of 46, XY DSDs is complex. Reverse phenotyping helps differentiate the abnormalities and explore the molecular etiology more accurately.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03719-y","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T18:27:41Z","timestamp":1744914461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The clinical diversity and molecular etiology in 46, XY disorders of sex development patients without uterus"],"prefix":"10.1186","volume":"20","author":[{"given":"Leilei","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duoduo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7461-4203","authenticated-orcid":false,"given":"Qinjie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"7","key":"3719_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41585-023-00754-x","volume":"20","author":"AP Reyes","year":"2023","unstructured":"Reyes AP, Le\u00f3n NY, Frost ER, Harley VR. Genetic control of typical and atypical sex development. Nat Rev Urol. 2023;20(7):434\u201351.","journal-title":"Nat Rev Urol"},{"key":"3719_CR2","doi-asserted-by":"crossref","unstructured":"Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006;118:E488\u2013E500.","DOI":"10.1542\/peds.2006-0738"},{"key":"3719_CR3","first-page":"866","volume":"81","author":"SY Pang","year":"1988","unstructured":"Pang SY, Wallace MA, Hofman L, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 1988;81:866\u201374.","journal-title":"Pediatrics"},{"key":"3719_CR4","doi-asserted-by":"crossref","unstructured":"Zhang W, Mao J, Wang X, Zhao Z, Zhang X, Sun B et al. The genetic spectrum of a Chinese series of patients with 46, XY disorders of the sex development. Andrology. 2024;12(1).","DOI":"10.1111\/andr.13446"},{"issue":"9","key":"3719_CR5","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.ejrad.2011.12.036","volume":"81","author":"SM Mansour","year":"2012","unstructured":"Mansour SM, Hamed ST, Adel L, Kamal RM, Ahmed DM. Does MRI add to ultrasound in the assessment of disorders of sex development? Eur J Radiol. 2012;81(9):2403\u201310.","journal-title":"Eur J Radiol"},{"issue":"3\u20134","key":"3719_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000083539","volume":"58","author":"TG Schulze","year":"2004","unstructured":"Schulze TG, McMahon FJ. Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum Hered. 2004;58(3\u20134):131\u20138. https:\/\/doi.org\/10.1159\/000083539.","journal-title":"Hum Hered"},{"key":"3719_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153417","volume":"4","author":"RM Baxter","year":"2013","unstructured":"Baxter RM, Vilain E. Translational genetics for diagnosis of human disorders of sex development. Annu Rev Genom Hum Genet. 2013;4:371\u201392.","journal-title":"Annu Rev Genom Hum Genet"},{"key":"3719_CR8","doi-asserted-by":"crossref","unstructured":"Hattori A, Fukami M. Nuclear receptor gene variants underlying disorders\/differences of sex development through abnormal testicular development. Biomolecules. 2023;13(4).","DOI":"10.3390\/biom13040691"},{"key":"3719_CR9","doi-asserted-by":"publisher","first-page":"111146","DOI":"10.1016\/j.mce.2020.111146","volume":"523","author":"NC Hornig","year":"2021","unstructured":"Hornig NC, Holterhus P-M. Molecular basis of androgen insensitivity syndromes. Mol Cell Endocrinol. 2021;523:111146.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"3719_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/cen.12857","volume":"84","author":"SF Ahmed","year":"2016","unstructured":"Ahmed SF, Achermann JC, Arlt W, Balen A, Conway G, Edwards Z, et al. Society for endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clin Endocrinol. 2016;84(5):771\u201388.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"3719_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1210\/jc.2010-1024","volume":"96","author":"L Maimoun","year":"2011","unstructured":"Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, et al. Phenotypical, biological, and molecular heterogeneity of 5\u03b1-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab. 2011;96(2):296\u2013307.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3719_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.2047-2927.2014.00215.x","volume":"2","author":"T Akcay","year":"2014","unstructured":"Akcay T, Fernandez-Cancio M, Turan S, G\u00fcran T, Audi L, Bereket A. AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity. Andrology. 2014;2(4):572\u20138.","journal-title":"Andrology"},{"issue":"9","key":"3719_CR13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41576-021-00365-5","volume":"22","author":"EC D\u00e9lot","year":"2021","unstructured":"D\u00e9lot EC, Vilain E. Towards improved genetic diagnosis of human differences of sex development. Nat Rev Genet. 2021;22(9):588\u2013602.","journal-title":"Nat Rev Genet"},{"key":"3719_CR14","doi-asserted-by":"crossref","unstructured":"Gomes NL, Chetty T, Jorgensen A, Mitchell RT. Disorders of sex Development-Novel regulators, impacts on fertility, and options for fertility preservation. Int J Mol Sci. 2020;21(7).","DOI":"10.3390\/ijms21072282"},{"issue":"4","key":"3719_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/bdrc.21145","volume":"108","author":"S Domenice","year":"2016","unstructured":"Domenice S, Machado AZ, Ferreira FM, Ferraz-de-Souza B, Lerario AM, Lin L, et al. Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals. Birth Defects Res C Embryo Today. 2016;108(4):309\u201320.","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"12","key":"3719_CR16","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/humu.23603","volume":"39","author":"R Sreenivasan","year":"2018","unstructured":"Sreenivasan R, Ludbrook L, Fisher B, Declosmenil F, Knower KC, Croft B, et al. Mutant NR5A1\/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer. Hum Mutat. 2018;39(12):1861\u201374.","journal-title":"Hum Mutat"},{"key":"3719_CR17","doi-asserted-by":"crossref","unstructured":"de Oliveira FR, Mazzola TN, de Mello MP, Francese-Santos AP, Lemos-Marini SHVd, Maciel-Guerra AT et al. DHX37 and NR5A1 variants identified in patients with 46,XY partial gonadal dysgenesis. Life (Basel). 2023;13(5).","DOI":"10.3390\/life13051093"},{"issue":"5\u20136","key":"3719_CR18","first-page":"258","volume":"13","author":"MF Faienza","year":"2019","unstructured":"Faienza MF, Chiarito M, Baldinotti F, Canale D, Savino C, Paradies G, et al. NR5A1 gene variants: variable phenotypes, new variants, different outcomes. sexual development: genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex. Determ Differ. 2019;13(5\u20136):258\u201363.","journal-title":"Determ Differ"},{"issue":"12","key":"3719_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1507\/endocrj.EJ18-0218","volume":"65","author":"M Adachi","year":"2018","unstructured":"Adachi M, Hasegawa T, Tanaka Y, Asakura Y, Hanakawa J, Muroya K. Spontaneous virilization around puberty in NR5A1-related 46,XY sex reversal: additional case and a literature review. Endocr J. 2018;65(12):1187\u201392.","journal-title":"Endocr J"},{"issue":"4","key":"3719_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1095\/biolreprod.115.131193","volume":"93","author":"T Karpova","year":"2015","unstructured":"Karpova T, Ravichandiran K, Insisienmay L, Rice D, Agbor V, Heckert LL. Steroidogenic factor 1 differentially regulates fetal and adult Leydig cell development in male mice. Biol Reprod. 2015;93(4):83.","journal-title":"Biol Reprod"},{"issue":"1","key":"3719_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000519047","volume":"16","author":"A Kumar","year":"2022","unstructured":"Kumar A, Sharma R, Faruq M, Kumar M, Sharma S, Werner R, et al. Clinical, biochemical, and molecular characterization of Indian children with clinically suspected androgen insensitivity syndrome. Sex Development: Genet Mol Biology Evol Endocrinol Embryol Pathol Sex Determ Differ. 2022;16(1):34\u201345.","journal-title":"Sex Development: Genet Mol Biology Evol Endocrinol Embryol Pathol Sex Determ Differ"},{"issue":"12","key":"3719_CR22","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1210\/jc.2019-00984","volume":"104","author":"TE da Silva","year":"2019","unstructured":"da Silva TE, Gomes NL, Ler\u00e1rio AM, Keegan CE, Nishi MY, Carvalho FM, et al. Genetic evidence of the association of DEAH-Box helicase 37 defects with 46,XY gonadal dysgenesis spectrum. J Clin Endocrinol Metab. 2019;104(12):5923\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3719_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41436-019-0606-y","volume":"22","author":"K McElreavey","year":"2020","unstructured":"McElreavey K, Jorgensen A, Eozenou C, Merel T, Bignon-Topalovic J, Tan DS, et al. Pathogenic variants in the DEAH-box RNA helicase DHX37 are a frequent cause of 46,XY gonadal dysgenesis and 46,XY testicular regression syndrome. Genet Med. 2020;22(1):150\u20139.","journal-title":"Genet Med"},{"issue":"5","key":"3719_CR24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/humu.22046","volume":"33","author":"B Gottlieb","year":"2012","unstructured":"Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M. The androgen receptor gene mutations database: 2012 update. Hum Mutat. 2012;33(5):887\u201394.","journal-title":"Hum Mutat"},{"issue":"11","key":"3719_CR25","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1210\/jc.2016-1990","volume":"101","author":"NC Hornig","year":"2016","unstructured":"Hornig NC, Ukat M, Schweikert HU, Hiort O, Werner R, Drop SLS, et al. Identification of an AR Mutation-Negative class of androgen insensitivity by determining endogenous AR activity. J Clin Endocrinol Metab. 2016;101(11):4468\u201377.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3719_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1055\/s-0032-1324725","volume":"30","author":"T Ogata","year":"2012","unstructured":"Ogata T, Sano S, Nagata E, Kato F, Fukami M. MAMLD1 and 46,XY disorders of sex development. Semin Reprod Med. 2012;30(5):410\u20136.","journal-title":"Semin Reprod Med"},{"key":"3719_CR27","doi-asserted-by":"crossref","unstructured":"Ilaslan E, Markosyan R, Sproll P, Stevenson BJ, Sajek M, Sajek MP et al. The FKBP4 gene, encoding a regulator of the androgen receptor signaling pathway, is a novel candidate gene for androgen insensitivity syndrome. Int J Mol Sci. 2020;21(21).","DOI":"10.3390\/ijms21218403"},{"issue":"5","key":"3719_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/09513590.2018.1540576","volume":"35","author":"F Yang","year":"2019","unstructured":"Yang F, Zhao Y, Lv J, Sheng X, Wang L. A new compound heterozygous mutation in a female with 17\u03b1-hydroxylase\/17,20-lyase deficiency, slipped capital femoral epiphysis, and adrenal myelolipoma. Gynecol Endocrinol. 2019;35(5):385\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"3719_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/TACG.S198178","volume":"13","author":"RL Batista","year":"2020","unstructured":"Batista RL, Mendonca BB. Integrative and analytical review of the 5-Alpha-Reductase type 2 deficiency worldwide. Appl Clin Genet. 2020;13:83\u201396.","journal-title":"Appl Clin Genet"},{"issue":"6","key":"3719_CR30","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jcem.87.6.8523","volume":"87","author":"JWM Martens","year":"2002","unstructured":"Martens JWM, Lumbroso S, Verhoef-Post M, Georget V, Richter-Unruh A, Szarras-Czapnik M, et al. Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency. J Clin Endocrinol Metab. 2002;87(6):2506\u201313.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3719_CR31","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.4158\/ACCR-2019-0152","volume":"6","author":"S Jahan","year":"2020","unstructured":"Jahan S, Abul Hasanat M, Alam F, Fariduddin M, Tofail T, Leydig cell hypoplasia:. a unique paradox in the diagnosis of 46,XY disorders of sex development. AACE Clin Case Rep. 2020;6(3):e117\u20132.","journal-title":"AACE Clin Case Rep"},{"key":"3719_CR32","doi-asserted-by":"crossref","unstructured":"D\u00e9lot EC, Vilain E. Towards improved genetic diagnosis of human differences of sex development. Nat Rev Genet. 2021;22(9):588\u2013602","DOI":"10.1038\/s41576-021-00365-5"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03719-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T18:27:45Z","timestamp":1744914465000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03719-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3719"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03719-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"5 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Peking Union Medical College Hospital Ethics Committee and was conducted according to the Declaration of Helsinki principles (No. JS-2510). Written informed consent was obtained from all adults or legal guardians of adolescents under 18 years old.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from all enrolled patients or their parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}